These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 20466604)

  • 21. Genomic medicine. Gene expression tests foretell breast cancer's future.
    Garber K
    Science; 2004 Mar; 303(5665):1754-5. PubMed ID: 15031473
    [No Abstract]   [Full Text] [Related]  

  • 22. A transcription/translation-based gene signature predicts resistance to chemotherapy in breast cancer.
    He DX; Xia YD; Gu XT; Jin J; Ma X
    J Pharm Biomed Anal; 2015 Jan; 102():500-8. PubMed ID: 25459950
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanisms of lapatinib resistance in HER2-driven breast cancer.
    D'Amato V; Raimondo L; Formisano L; Giuliano M; De Placido S; Rosa R; Bianco R
    Cancer Treat Rev; 2015 Dec; 41(10):877-83. PubMed ID: 26276735
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The 70-gene signature as a response predictor for neoadjuvant chemotherapy in breast cancer.
    Straver ME; Glas AM; Hannemann J; Wesseling J; van de Vijver MJ; Rutgers EJ; Vrancken Peeters MJ; van Tinteren H; Van't Veer LJ; Rodenhuis S
    Breast Cancer Res Treat; 2010 Feb; 119(3):551-8. PubMed ID: 19214742
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The emergence of targeted drugs in breast cancer to prevent resistance to endocrine treatment and chemotherapy.
    Austreid E; Lonning PE; Eikesdal HP
    Expert Opin Pharmacother; 2014 Apr; 15(5):681-700. PubMed ID: 24579888
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intrinsic and acquired resistance to HER2-targeted therapies in HER2 gene-amplified breast cancer: mechanisms and clinical implications.
    Rexer BN; Arteaga CL
    Crit Rev Oncog; 2012; 17(1):1-16. PubMed ID: 22471661
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional genomic analysis of drug sensitivity pathways to guide adjuvant strategies in breast cancer.
    Swanton C; Szallasi Z; Brenton JD; Downward J
    Breast Cancer Res; 2008; 10(5):214. PubMed ID: 18986507
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gene-expression signatures in breast cancer.
    Sotiriou C; Pusztai L
    N Engl J Med; 2009 Feb; 360(8):790-800. PubMed ID: 19228622
    [No Abstract]   [Full Text] [Related]  

  • 29. Breast carcinoma with amplified HER2: a gene expression signature specific for trastuzumab resistance and poor prognosis.
    Khoury T; Kanehira K; Wang D; Ademuyiwa F; Mojica W; Cheney R; Morrison C; Conroy J; Nowak N; Liu S
    Mod Pathol; 2010 Oct; 23(10):1364-78. PubMed ID: 20657551
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of the epidermal growth factor receptor in breast cancer.
    Chan SK; Hill ME; Gullick WJ
    J Mammary Gland Biol Neoplasia; 2006 Jan; 11(1):3-11. PubMed ID: 16947082
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Receptor-based predictors of response in breast cancer.
    McGovern UB; Stebbing J
    Future Oncol; 2009 Apr; 5(3):283-6. PubMed ID: 19374534
    [No Abstract]   [Full Text] [Related]  

  • 32. A functional genetic approach identifies the PI3K pathway as a major determinant of trastuzumab resistance in breast cancer.
    Berns K; Horlings HM; Hennessy BT; Madiredjo M; Hijmans EM; Beelen K; Linn SC; Gonzalez-Angulo AM; Stemke-Hale K; Hauptmann M; Beijersbergen RL; Mills GB; van de Vijver MJ; Bernards R
    Cancer Cell; 2007 Oct; 12(4):395-402. PubMed ID: 17936563
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genomics in breast cancer-therapeutic implications.
    Lønning PE; Sørlie T; Børresen-Dale AL
    Nat Clin Pract Oncol; 2005 Jan; 2(1):26-33. PubMed ID: 16264853
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Will single-time tumor profiling and a "guilt by association" approach allow us to outsmart HER2-positive breast cancer?
    Arteaga CL
    Clin Cancer Res; 2007 Feb; 13(4):1071-3. PubMed ID: 17317812
    [No Abstract]   [Full Text] [Related]  

  • 35. Integrated Analysis of RNA and DNA from the Phase III Trial CALGB 40601 Identifies Predictors of Response to Trastuzumab-Based Neoadjuvant Chemotherapy in HER2-Positive Breast Cancer.
    Tanioka M; Fan C; Parker JS; Hoadley KA; Hu Z; Li Y; Hyslop TM; Pitcher BN; Soloway MG; Spears PA; Henry LN; Tolaney S; Dang CT; Krop IE; Harris LN; Berry DA; Mardis ER; Winer EP; Hudis CA; Carey LA; Perou CM
    Clin Cancer Res; 2018 Nov; 24(21):5292-5304. PubMed ID: 30037817
    [No Abstract]   [Full Text] [Related]  

  • 36. Novel targeted therapies to overcome trastuzumab resistance in HER2-overexpressing metastatic breast cancer.
    Huang Y; Fu P; Fan W
    Curr Drug Targets; 2013 Jul; 14(8):889-98. PubMed ID: 23531110
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gene expression profiles of breast cancer obtained from core cut biopsies before neoadjuvant docetaxel, adriamycin, and cyclophoshamide chemotherapy correlate with routine prognostic markers and could be used to identify predictive signatures.
    Rody A; Karn T; Gätje R; Kourtis K; Minckwitz G; Loibl S; Munnes M; Ruckhäberle E; Holtrich U; Kaufmann M; Ahr A
    Zentralbl Gynakol; 2006 Apr; 128(2):76-81. PubMed ID: 16673249
    [TBL] [Abstract][Full Text] [Related]  

  • 38. YWHAE promotes proliferation, metastasis, and chemoresistance in breast cancer cells.
    Yang YF; Lee YC; Wang YY; Wang CH; Hou MF; Yuan SF
    Kaohsiung J Med Sci; 2019 Jul; 35(7):408-416. PubMed ID: 31001932
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The use of microarray technology in the management of breast cancer.
    Pusztai L
    Clin Adv Hematol Oncol; 2007 Mar; 5(3):193-4, 197. PubMed ID: 17519880
    [No Abstract]   [Full Text] [Related]  

  • 40. De-escalation of treatment in HER2-positive breast cancer: Determinants of response and mechanisms of resistance.
    Veeraraghavan J; De Angelis C; Reis-Filho JS; Pascual T; Prat A; Rimawi MF; Osborne CK; Schiff R
    Breast; 2017 Aug; 34 Suppl 1(Suppl 1):S19-S26. PubMed ID: 28687441
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.